Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Cybin IRL describes new 5-HT2 receptor agonists

March 15, 2022

Chengdu Fanxi Biopharma discovers thyroid hormone receptor alpha/beta agonists

March 14, 2022

Medshine Discovery discloses new S1PR1 agonists

March 11, 2022

Bristol Myers Squibb describes FPR2 and FPR1 agonists

March 8, 2022

Prodrugs of clopidogrel's active metabolite identified by Shanghai Curegene Pharmaceutical

Feb. 24, 2022

Novel target identified for long QT

Feb. 23, 2022

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Feb. 23, 2022

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Feb. 23, 2022

Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists

Feb. 22, 2022

Alkem signs license agreement with Harvard for technology to treat vascular disease

Feb. 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...